title: Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism.
authors.affiliation: Department of Medicine, Montreal Heart Institute, Quebec, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Nattel
authors.forename: S
authors.initials: S
authors.lastname: Ranger
authors.forename: M
authors.initials: M
authors.lastname: Talajic
authors.forename: R
authors.initials: R
authors.lastname: Lemery
authors.forename: D
authors.initials: D
authors.lastname: Roy
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000368:Aged; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D004285:Dogs; D004562:Electrocardiography; D004917:Erythromycin / Q000009:adverse effects* / Q000633:toxicity; D006801:Humans; D066298:In Vitro Techniques; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000503:physiopathology; D008297:Male; D011690:Purkinje Fibers / Q000187:drug effects; D011802:Quinidine / Q000009:adverse effects*; D013610:Tachycardia / Q000139:chemically induced* / Q000503:physiopathology
chemical_list: D004917:Erythromycin; D011802:Quinidine